About this Research Topic
The goal of this Research Topic is to explore novel pathways in AML which can be exploited for therapy of either upfront or relapse/refractory AML as well as in the maintenance setting. An area of specific interest to be explored in this Research Topic is targeted maintenance therapy post allogeneic transplantation.
Subtopics of interests include but not limited to:
- Identifications of novel pathways for targeted therapies for AML: upfront, relapsed/refractory/ post-transplant maintenance.
- Combinational therapeutic strategies with chemotherapeutic, radiotherapeutic immunotherapeutic, targeted agents for AML.
- Pharmacology, preclinical or clinical studies of novel targeted drugs for AML.
Manuscripts including novel research and reviews are welcome.
Manuscripts consisting solely of bioinformatics, computational analysis, or predictions of public databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) will not be accepted in any of the sections of Frontiers in Oncology.
Keywords: acute myeloid leukemia, targeted therapies, novel mechanisms, clinical trials, stem cell transplant
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.